Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 5 years by 8.86% on an annualized basis producing an average annual return of 17.41%. Currently, Regeneron Pharmaceuticals has a market capitalization of $82.31 billion.
Buying $1000 In REGN: If an investor had bought $1000 of REGN stock 5 years ago, it would be worth $2,276.58 today based on a price of $755.78 for REGN at the time of writing.
Regeneron Pharmaceuticals’s Performance Over Last 5 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
